No Data
Trending Stocks as Wall Street Bounces Back With Strong Week
Express News | JPMorgan Analyst Richard Vosser: (In the context of negotiations in the USA to lower Pharmaceutical prices) expects that Novo-Nordisk A/S weight loss drugs Ozempic and Rybelsus will see a net discount of 50% on about 30% of their sales in the Medicare Par
Express News | Novo-Nordisk A/S: The 3rd phase clinical trial of 7.2mg semaglutide achieved its primary endpoint, with a 20.7% weight loss at 72 weeks.
The king of Luxury Goods returns: LVMH surpasses Novo-Nordisk A/S, reclaiming the top spot in Europe's Market Cap.
①LVMH's market value surpasses Novo-Nordisk A/S, regaining the title of the most valuable Listed in Hong Kong company in Europe; ②LVMH's stock price fell 13% last year, but signs of Industry recovery and positive earnings reports from peers have raised expectations, leading analysts at Bank of America to upgrade LVMH's rating to 'Buy'; ③Novo-Nordisk A/S is affected by multiple factors including supply and Pharmaceutical pricing concerns, an increasingly competitive environment, and disappointing results from experimental drug trials.
These Stocks Moved the Most Today: Apple, Alphabet, Qorvo, Novo Nordisk, SLB, J.B. Hunt, Rivian, and More -- Barrons.com
Sector Update: Health Care Stocks Decline Late Afternoon